Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is believed to work by stimulating the detoxification of ammonia in the liver and promoting protein synthesis.
## Primary Indications
* Treatment of latent and manifest hepatic encephalopathy.
## Adult Dosing
* **Standard Dose:** 6 grams to 18 grams per day, divided into 3 doses.
* **Route:** Oral or intravenous.
* Oral: Typically given as sachets or granules.
* Intravenous: Usually given as an infusion. Specific infusion rates and concentrations depend on product formulation and clinical judgment.
* **Maximum Dose:** Doses up to 24 grams per day have been used, but higher doses are not typically recommended without further evidence.
## Pediatric Dosing
* There is limited established pediatric dosing for Hepamerz. Dosing should be guided by clinical expertise and available pediatric literature, often extrapolated from adult data.
## Dose Adjustments
* No specific dose adjustments are routinely recommended for renal or hepatic impairment, as the drug's metabolism is primarily hepatic. However, caution is advised in patients with severe liver dysfunction, and close monitoring is essential.
## Contraindications
* Hypersensitivity to l-ornithine, l-aspartate, or any component of the formulation.
* Severe kidney disease (due to potential accumulation of amino acids).
## Adverse Effects
* **Common:** Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain).
* **Less Common:** Dizziness, headache, fatigue, skin rash.
* **Rare:** Allergic reactions.
## Key Drug Interactions
* No significant drug interactions have been definitively established. However, caution should be exercised when co-administering with other drugs that affect ammonia levels or liver function.
## Monitoring
* Monitor for signs and symptoms of hepatic encephalopathy (e.g., confusion, asterixis).
* Monitor electrolytes and renal function, especially in patients with pre-existing renal compromise.
* Assess for gastrointestinal side effects.
## Clinical Pearls
* The efficacy of Hepamerz may be influenced by factors such as the severity of liver disease and the underlying cause of hepatic encephalopathy.
* For intravenous administration, ensure appropriate dilution and infusion rate to avoid local irritation or adverse events.
* Treatment duration should be individualized based on patient response and clinical goals.
***
*Disclaimer: This information is intended for clinical professionals and does not replace the need to consult the most current prescribing information, relevant literature, and institutional protocols. Always verify drug information with reliable sources before administration.*
